Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Enveric Biosciences, Inc. (ENVB) had Pre-Tax Income of $-1.63M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.63M |
|
-- |
|
-- |
|
$1.63M |
|
$-1.63M |
|
$-0.00M |
|
|
Pre-Tax Income |
$-1.63M |
$-1.63M |
|
$-1.63M |
|
$-1.63M |
|
$-1.63M |
|
$-1.63M |
|
$-1.63M |
|
$-1.60M |
|
1.51M |
|
1.51M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$5.38M |
|
$0.12M |
|
$0.15M |
|
$5.52M |
|
$0.46M |
|
-- |
|
-- |
|
$0.46M |
|
$5.06M |
|
$5.06M |
|
$5.06M |
|
1.89M |
|
| Cash Flow Statement Financials | |
$-2.26M |
|
-- |
|
$2.50M |
|
$4.68M |
|
$4.91M |
|
$0.23M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.28% |
|
-32.28% |
|
-29.58% |
|
-32.28% |
|
$2.68 |
|
$-1.49 |
|
$-1.49 |
|